ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

http://www.ericll.org/

 

Videos
72:55

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

Expert Discussion on Frontline CLL: Is There Still a Role for Chemoimmunotherapy? What Is the Efficacy of FCR? How Important Is Biological Profiling? Does MRD Affect Therapeutic Strategies?

FEATURING Jennifer Woyach, John Seymour, Kirsten Fischer, Florencia Cymbalista, George Follows, Michael Hallek, Alessandra Tedeschi, Matthew Davids, William Wierda
  • 29 views
  • December 21, 2020
75:59

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

Expert Discussion on R/R CLL: Can We Continue Monotherapy After 2 yrs? Is Continuous Therapy Preferable for TP53-Mutated Pts? Should We Go After Transplant if MRD+ or Can We Use FCR?

FEATURING Michel Van Gelder, Jennifer Brown, Arnon Kater, Antonio Cuneo, Peter Hillmen, Barbara Eichhorst, Stephen Schuster
  • 25 views
  • December 21, 2020
14:36

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on CLL: How to Measure Proliferation by Heavy Water Labeling? What Are the Mechanisms of Action of Ibrutinib?

FEATURING Jan Burger
  • 123 views
  • December 17, 2020
  • 1
14:36

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on CLL: Does IL4I1 Promote Disease Development? Can We Associate It With CD8 T-Cell Exhaustion?

FEATURING Martina Seiffert
  • 15 views
  • December 17, 2020
13:24

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on CLL: Does Activation of Toll-Like Receptors Correlate With BCR Engagement? What Is the Impact of Ibrutinib on Tumor-Microenvironment Interactions?

FEATURING Adrian Wiestner
  • 17 views
  • December 17, 2020
14:29

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on BCL-2 in R/R CLL: Can Navitoclax Prolong PFS? Does Venetoclax Help Reduce Disease Burden?

FEATURING John Seymour
  • 122 views
  • December 17, 2020
  • 1
17:39

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on Cell-Extrinsic Drivers in CLL: Do Microenvironmental Signals Increase Cell Survival and Induce Venetoclax Resistance? How Can Kinase Inhibitors Interfere?

FEATURING Dimitar Efremov
  • 110 views
  • December 17, 2020
  • 1
16:43

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on Cell-Intrinsic Drivers in CLL: Does Ibrutinib Prolong PFS in Untreated Older Patients? How Do BCL2, BTK and PLCg2 Mutations Work as Mechanisms of Resistance?

FEATURING Stephan Stilgenbauer
  • 131 views
  • December 17, 2020
13:05

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Highlights on Richter Syndrome in CLL: Clonally Related vs. Unrelated DLCL Variants, Chemo Principle, BCR Signaling, Genomic Complexity, Immune CPIs

FEATURING Davide Rossi
  • 126 views
  • December 17, 2020
  • 1
17:47

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Highlights on CLL: What Does NGS Result With in CLL? How Does IO Shape the Evolutionary Dynamics? What Is the Role of ClonMapper?

FEATURING Catherine Wu
  • 15 views
  • December 17, 2020
13:54

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on CLL: Analysis of Spontaneous Regression - Proliferation and Trafficking Potential, T-Cell Phenotype, Reversing the Process

FEATURING Tatjana Stankovic
  • 122 views
  • December 17, 2020
  • 1
12:45

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on CLL: Diagnostic Considerations, Comparison With MCL, Typical vs. Atypical Disease, Cell of Origin, Clonal Diversification/Evolution

FEATURING Andy Rawstron
  • 15 views
  • December 17, 2020
14:38

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Updates on CLL: How to Define MBL and What Are the Features Related to CLL? How Does LC/HC-MBL Affect Immune Response?

FEATURING Lydia Scarfò
  • 17 views
  • December 17, 2020
33:24

ERIC 2020 Virtual Meeting: New Frontiers in CLL Research

2020 Highlights on CLL: Genomic Changes, Dominance of IGHV1-69, Natural IgM Antibodies, Role of T-Cells, U-CLL/M-CLL Differences

FEATURING Freda Stevenson
  • 20 views
  • December 15, 2020